5-Amino-1MQ (5A1MQ)

Metabolic Preclinical

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule compound that acts as a potent and selective inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme that regulates cellular metabolism and energy expenditure. By inhibiting NNMT, 5-Amino-1MQ can potentially increase NAD+ levels and enhance fat cell metabolism. Research has shown that NNMT is overexpressed in obesity and type 2 diabetes, making it an attractive target for metabolic disorders. In preclinical studies, NNMT inhibition led to reduced fat mass, improved glucose tolerance, and prevention of diet-induced obesity without affecting food intake.

Key Data

Research Status
Preclinical
Half-Life
Unknown
Administration
Oral
Typical Dosage
50-150 mg oral
Molecular Weight
173.21 Da
Molecular Formula
C10H11N2+

Mechanism of Action

Inhibits nicotinamide N-methyltransferase (NNMT), increasing NAD+ levels and improving fat cell metabolism.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home